Table 2.
ANMs |
ASHAs |
|||||
---|---|---|---|---|---|---|
Total |
Category-I |
Category-II |
Total |
Category-I |
Category-II |
|
N = 220 |
N = 100 |
N = 73 |
N = 235 |
N = 100 |
N = 85 |
|
Percentage (95% CI) | Percentage (95% CI) | Percentage (95% CI) | Percentage (95% CI) | Percentage (95% CI) | Percentage (95% CI) | |
Falciparum malaria |
|
|
|
|
|
|
Treatment of children for falciparum infection as per policy |
0 |
0 |
0 |
0 |
0 |
0 |
Treatment of non-pregnant adult for falciparum infection as per the policy |
47.7 (41.1-54.3) |
72.0 (62.6-80.1) |
45.2 (34.0-56.7) |
27.6 (22.2-33.6) |
48.0 (38.3-57.7) |
20.0 (12.5-29.5) |
Refer falciparum-positive children and non-pregnant adults patient for treatment to health facility |
55.0 (48.3-61.4) |
38.0 (28.8-47.7) |
50.6 (39.3-62.0) |
71.4 (65.4-76.9) |
60.0 (50.1-69.2) |
68.2 (57.7-77.4) |
Vivax malaria |
|
|
|
|
|
|
Treatment of vivax infection in children as per policy |
02.7 (01.1-05.5) |
02.0 (0.33-6.45) |
05.5 (01.7-12.6) |
0.42 (0.02-2.08) |
0 |
1.1 (0.05-5.6) |
Treatment of vivax infection in non-pregnant adults as per policy |
47.2 (40.7-53.8) |
66.0 (56.3-74.7) |
52.0 (40.6-63.3) |
24.2 (19.1-30.0) |
34.0 (25.2-43.6) |
27.0 (18.4-37.2) |
Refer vivax malaria-positive children and non-pregnant adults patient for treatment to health facility | 60.9 (54.3-67.2) | 48.0 (38.3-57.7) | 53.4 (41.9-64.6) | 75.7 (69.9-80.9) | 65.0 (55.2-73.8) | 74.1 (64.0-82.5) |